Lothar Schweigerer
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism 22
- Molecular Biology top 1%
- Fibroblast Growth Factor Research 13
- Angiogenesis and VEGF in Cancer 12
- Cell Biology top 0.5%
- Proteoglycans and glycosaminoglycans research 5
- Immunology and Allergy top 2%
- Oncology top 2%
- Lymphatic System and Diseases 8
-
- Neuroblastoma Research and Treatments 27
-
- Neuropeptides and Animal Physiology 7
-
- Virus-based gene therapy research 6
- Co-authors
- Denis GospodarowiczGera NeufeldNapoleone FerraraMichael S. PepperRoberto MontesanoHerman AdlercreutzTheodore FotsisMatthias Mann
- Journals
- Biochemical and Biophysical Research Communications (9 papers)International Journal of Cancer (5 papers)Nature (4 papers)
- Partner nations
- GermanyUnited StatesGreece
In The Last Decade
Lothar Schweigerer
86 papers receiving 9.1k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Cancer Research 1.5k
- Molecular Biology 5.5k
- Cell Biology 1.2k
- Immunology and Allergy 334
- Oncology 1.4k
Countries citing papers authored by Lothar Schweigerer
This map shows the geographic impact of Lothar Schweigerer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lothar Schweigerer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lothar Schweigerer more than expected).
Fields of papers citing papers by Lothar Schweigerer
This network shows the impact of papers produced by Lothar Schweigerer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lothar Schweigerer. The network helps show where Lothar Schweigerer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lothar Schweigerer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 82 | |
| 2 | 2007 | 43 | |
| 3 | 2006 | 69 | |
| 4 | 2006 | 100 | |
| 5 | 2005 | 3 | |
| 6 | 2004 | 3 | |
| 7 | 2004 | 20 | |
| 8 | 2003 | 14 | |
| 9 | 2001 | 58 | |
| 10 | 2000 | 6 | |
| 11 | 1999 | 64 | |
| 12 | 1998 | 18 | |
| 13 | 1995 | 3 | |
| 14 | 1995 | 19 | |
| 15 | 1994 | 71 | |
| 16 | The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growthbreakdown → | 1994 | 638 |
| 17 | 1992 | 56 | |
| 18 | 1991 | 10 | |
| 19 | 1988 | 70 | |
| 20 | 1987 | 51 |
About Lothar Schweigerer
Lothar Schweigerer is a scholar working on Neurology, Cancer Research and Cell Biology, having authored 87 papers that have together received 9.5k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (27 papers), Cancer, Hypoxia, and Metabolism (22 papers), Fibroblast Growth Factor Research (13 papers), Angiogenesis and VEGF in Cancer (12 papers), Lymphatic System and Diseases (8 papers), Neuropeptides and Animal Physiology (7 papers), Virus-based gene therapy research (6 papers) and Proteoglycans and glycosaminoglycans research (5 papers). The work is most often cited by research in Cancer Research (1.5k citations), Molecular Biology (5.5k citations) and Cell Biology (1.2k citations). Lothar Schweigerer has collaborated with scholars based in Germany, United States and Greece. Frequent co-authors include Denis Gospodarowicz, Gera Neufeld, Napoleone Ferrara, Michael S. Pepper, Roberto Montesano, Herman Adlercreutz, Theodore Fotsis, Matthias Mann, Andriy Shevchenko and Matthias Wilm. Their work appears in journals such as Biochemical and Biophysical Research Communications, International Journal of Cancer, Nature, Proceedings of the National Academy of Sciences and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.